• Bristol Myers Squibb average ebitda margin for 2024 was 6.52%, a 84.1% increase from 2023.
• Bristol Myers Squibb average ebitda margin for 2023 was 41.01%, a 6.46% decline from 2022.
• Bristol Myers Squibb average ebitda margin for 2022 was 38.52%, a 80.93% increase from 2021.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.